Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Enflurane
Drug ID BADD_D00770
Description Enflurane is a halogenated inhalational anesthetic initially approved by the FDA in 1972. Since this date, it has been withdrawn from the US market.[L13646,L13649] Unlike its other inhalational anesthetic counterparts including [isoflurane] and [halothane], enflurane is known to induce seizure activity. In addition, it is known to cause increased cardio depressant effects when compared to other inhaled anesthetics.[A202022]
Indications and Usage Enflurane may be used for both the induction and maintenance of general anesthesia. It can also be used to induce analgesia for vaginal delivery. Low concentrations of enflurane can also be used as an adjunct to general anesthetic drugs during delivery by Cesarean section.[L13646]
Marketing Status approved; investigational; vet_approved
ATC Code N01AB04
DrugBank ID DB00228
KEGG ID D00543
MeSH ID D004737
PubChem ID 3226
TTD Drug ID D0AO9S
NDC Product Code Not Available
UNII 91I69L5AY5
Synonyms Enflurane | Etran | Enlirane | Ethrane | Alyrane | Enfran
Chemical Information
Molecular Formula CHF2OCF2CHClF
CAS Registry Number 13838-16-9
SMILES C(C(OC(F)F)(F)F)(F)Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaesthesia17.02.06.036---
Arrhythmia02.03.02.001---
Body temperature increased13.15.01.001---
Carbon dioxide decreased13.02.01.012---
Chills08.01.09.001; 15.05.03.016--
Hepatic failure09.01.03.002--
Hepatic necrosis09.01.07.002--
Hepatotoxicity09.01.07.009; 12.03.01.008---
Hyperkalaemia14.05.03.001--
Hyperthermia malignant08.05.01.002---
Hypocapnia22.02.02.008---
Hypotension24.06.03.002--
Hypoxia22.02.02.003--
Injury12.01.08.004---
Nausea07.01.07.001--
Psychomotor hyperactivity17.01.02.011; 19.11.02.003---
Respiratory depression17.02.05.047; 22.02.01.010---
Seizure17.12.03.001--
Vomiting07.01.07.003--
White blood cell count increased13.01.06.013---
Transaminases increased13.03.04.036---
Pulmonary function test decreased13.19.01.001---
Liver injury09.01.07.022; 12.01.17.012---
Traumatic liver injury09.01.08.010; 12.01.17.027---
The 1th Page    1    Total 1 Pages